H Onodera1, M Okamoto, S Takemura
1Division of Pulmonary Disease, Yosanoumi Kyoto Prefectural Hospital.
Ibudilast inactivates the alternative complement pathway, reducing allergic reactions in asthma patients. This mechanism involves altering complement fragments like Bb and anaphylatoxins, offering a new therapeutic approach for bronchial asthma.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: